CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-19 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,440 | $67.00 | $297K | 61,480 |
| 2026-03-18 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,330 | $68.71 | $298K | 65,920 |
| 2026-03-17 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,286 | $69.42 | $298K | 70,250 |
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion | +26,482 | 74,536 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −4,790 | 0 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −8,148 | 8,148 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −8,020 | 16,040 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −5,524 | 16,574 | ||
| 2026-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +30,724 | 30,724 | ||
| 2026-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Restricted Stock Units | +19,306 | 19,306 | ||
| 2025-06-09 | Mottiwala Aziz Chief Commercial Officer | Sale 10b5-1 | −17,500 | $43.76 | $766K | 47,557 |
| 2025-03-20 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,365 | $50.11 | $169K | 65,057 |
| 2025-03-19 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,557 | $47.40 | $169K | 68,422 |
| 2025-03-18 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,643 | $46.29 | $169K | 71,979 |
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion | +20,957 | 75,622 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −4,790 | 4,790 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −8,148 | 16,296 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −8,019 | 24,060 | ||
| 2025-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +33,691 | 33,691 | ||
| 2025-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Restricted Stock Units | +22,098 | 22,098 |
Page 1 of 2 · 40 trades